Veteran trader Jay Woods has a warning for investors looking to play the SpaceX IPO

SpaceX is set to begin trading Friday at a fixed IPO price of $135 per share, implying a $1.77 trillion valuation if its EchoStar and Cursor transactions close. Jay Woods and Morningstar both warned the stock looks richly valued, with Morningstar calling it "significantly overvalued" and valuing it at roughly half the debut level. The article advises investors to avoid chasing the IPO and instead wait for pullbacks in what is expected to be a volatile debut.

Analysis

The immediate winner is not the IPO itself but the private-market carry complex that helped validate a very large mark-up. A listing at this size and price will reset underwriting standards across late-stage venture, and the first-order casualty is likely any comparable pre-IPO unicorn still priced off scarcity rather than cash-flow credibility. That matters for growth managers: if this deal prints weak, it bleeds into a broader de-rating of “story-first, metric-later” software/space adjacencies, while if it holds, it entrenches a higher tolerance for extreme duration risk.

The cleaner relative trade is against the sentiment beneficiaries that already traded on the Elon/Musk halo. TSLA is the obvious second-order pressure point: a headline-grabbing SpaceX tape can pull attention, capital, and narrative premium away from Tesla even though the businesses are unrelated. More importantly, a volatile debut can create intermittent liquidity events across the shareholder ecosystem, which tends to tighten risk budgets for high-beta retail favorites over the next few weeks.

The main catalyst window is the first 1-6 sessions after trading begins, when price discovery and allocator discipline matter more than fundamentals. If the stock gaps and then fails to hold on heavy volume, that’s the setup for a fast air pocket because the buyer base will be dominated by momentum rather than long-only fundamental holders. Conversely, a stable first-week hold would suggest the market is comfortable underwriting scarcity at almost any price, which is a warning sign for broader speculative froth rather than a green light.

The contrarian point is that the consensus may be too focused on absolute valuation and not enough on the signaling value of the transaction. A deal this large can function as a valuation anchor for adjacent private assets, especially if secondary demand is strong and lock-up expectations are benign. In that scenario, the short-term “overvalued” call may be correct but poorly timed; the better expression may be selling strength after the first post-debut squeeze rather than fading the open blindly.

Key Decisions for Investors

• Trade TSLA as a proxy hedge: initiate a small short into the SpaceX debut and cover into any 3-5 day post-listing volatility spike; risk/reward favors a tactical trade rather than a structural short.
• Avoid chasing the IPO in size; if access exists, use a starter position only after the first 1-2 sessions and require either a pullback or base-building volume confirmation.
• For event-driven books, buy downside protection on high-beta growth/space-adjacent baskets over the next 2 weeks; the convexity is cheap relative to the probability of a failed first-week hold.
• If the debut opens >20% above issue and fades intraday on heavy volume, use that as a short-entry trigger for a 1-3 week mean-reversion trade; invalidation is a sustained close above the opening-day high.
• Monitor MORN only as a sentiment read-through: a firmer-than-expected aftermarket would argue the market is discounting valuation discipline broadly, which is negative for other over-earnings-duration names.